Health Affairs, 22, no. 3 (2003): 149-158
doi: 10.1377/hlthaff.22.3.149
© 2003 by Project HOPE
 
New Online
 * Getting Health Reform Done
 * After the State of the Union
 * Incremental Reform
 * E-Health in Developing World
 * Most-Read Articles in 2009
This Article
* Abstract Freely available
* Full Text (HTML)
* Reprint (PDF)
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via HighWire
* Citing Articles via Web of Science (21)
* Citing Articles via Google Scholar
Google Scholar
* Articles by Huskamp, H. A.
* Articles by Blumenthal, D.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by Huskamp, H. A.
* Articles by Blumenthal, D.
Related Collections
* Medicare
* Military Medicine
* Pharmaceuticals

The Impact Of A National Prescription Drug Formulary On Prices, Market Share, And Spending: Lessons For Medicare?

Haiden A. Huskamp, Arnold M. Epstein and David Blumenthal



View larger version (11K):

[in a new window]
 
EXHIBIT 2 Market Shares In The Veterans Health Administration (VHA) National Formulary For Two Proton Pump Inhibitors (Closed Class), October 1994–July 1999

 


View larger version (20K):

[in a new window]
 
EXHIBIT 3 Market Shares In The Veterans Health Administration (VHA) National Formulary For HMG-CoA Reductase Inhibitors (Closed Class), October 1994–July 1999

 


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?